Carcinogenicity of procarbazine.
D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D002273:Carcinogens; D002277:Carcinoma / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D004424:Ear Canal; D004428:Ear Neoplasms / Q000139:chemically induced / Q000473:pathology; D005260:Female; D007274:Injections, Intraperitoneal; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000473:pathology; D009369:Neoplasms / Q000139:chemically induced*; D010212:Papilloma / Q000139:chemically induced; D011344:Procarbazine / Q000008:administration & dosage; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014594:Uterine Neoplasms / Q000139:chemically induced / Q000473:pathology
D002273:Carcinogens; D011344:Procarbazine